Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy.
about
Phage therapy: concept to cureNatural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Phage cocktails and the future of phage therapyColonisation of a phage susceptible Campylobacter jejuni population in two phage positive broiler flocksEncapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing AntibodiesThe long-term dynamics of Campylobacter colonizing a free-range broiler breeder flock: an observational studyGenetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteriaComputational models of populations of bacteria and lytic phage.The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-LactamsA method for generation phage cocktail with great therapeutic potential.Modeling bacteriophage amplification as a predictive tool for optimized MALDI-TOF MS-based bacterial detection.Influence of environmental variables in the efficiency of phage therapy in aquacultureReduction of Campylobacter jejuni in broiler chicken by successive application of group II and group III phages.Population dynamics of a Salmonella lytic phage and its host: implications of the host bacterial growth rate in modellingA window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.Campylobacters and their bacteriophages from chicken liver: The prospect for phage biocontrol.Mammalian Host-Versus-Phage immune response determines phage fate in vivo.Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.The Minor Flagellin of Campylobacter jejuni (FlaB) Confers Defensive Properties against Bacteriophage InfectionExploring the risks of phage application in the environment.Phage therapy: eco-physiological pharmacology.Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni.Host adaption to the bacteriophage carrier state of Campylobacter jejuni.Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage.Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains.Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host LethalityBacteriophage therapy and the mutant selection windowCoverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails.Regulators of calcium homeostasis identified by inference of kinetic model parameters from live single cells perturbed by siRNA.Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release.Use of logistic regression for prediction of the fate of Staphylococcus aureus in pasteurized milk in the presence of two lytic phages.Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communitiesReduction of invasive bacteria in ethanol fermentations using bacteriophages.In vitro assessment of the susceptibility of planktonic and attached cells of foodborne pathogens to bacteriophage p22-mediated salmonella lysates.Effect of bacteriophage application on Campylobacter jejuni loads in commercial broiler flocksHost range and in vitro lysis of Listeria monocytogenes seafood isolates by bacteriophages.A need for careful consideration of bacteriophage therapyBacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms.Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds.
P2860
Q21131139-F7E9510F-9962-407B-8CB7-80C0A92549FAQ24563742-913C9B07-AD76-40B3-826A-E37887A0FD2DQ26995797-A0EAAD26-CA47-4A3D-ACA9-F113470813FEQ28537874-5175A3B5-3BAF-4A8C-9FA6-0ABD7CBA04D7Q28551599-3085DC0A-CD6C-4662-8CAD-1B4D1E48E7F2Q28649996-1773FE03-A4C4-43E6-9E95-293B9CFCF72EQ28748827-3D838479-3EC6-42F6-A440-1814BA0747C7Q30251932-978D2734-7BF2-4051-B455-AB5965269E6EQ30988850-6505F1AC-4EC5-4F08-9D7E-2E74939151E6Q33696025-9339EAC5-C682-4B8C-BCC8-3080107FFAE4Q34187102-7E826A22-C79E-4578-8065-C7F96F479F37Q34475381-B2361DE8-E887-41FD-B7F8-59A6ED8CD95AQ34498214-357594B5-6A4E-4632-9F43-90B761ECC1D4Q34663447-6713556B-F431-4B22-9A62-A5364458FCBEQ35211072-FB7B4856-61E5-4266-A135-4CE71466C2E0Q35279671-85700E28-A272-40AA-BCDC-8B962471F032Q36114497-26D5681E-D16F-4643-BB67-88E9FD33E9BBQ36123704-8D4E2D95-94B2-4A14-B4F9-A1395DDB2325Q37335751-7D0AA8CD-3309-40FC-A5CF-FE54D9205567Q37447180-A8F43DD5-364C-4E5C-904D-59DF0E0BCE76Q38172129-EE076AA9-6F62-4E14-876F-C525F1CDAFE2Q38230407-85CD769A-C8D6-4977-B0EC-17BD6D9518E6Q38576127-18AF4DDD-171A-47D0-B18E-C2F4EE40BBC2Q38871507-EEC51ED5-C7F8-4BC0-9271-440A08E826DDQ39544046-743DEF35-408D-4929-93ED-D2881B98A6D1Q40121530-319CE5E1-C0EA-4D09-BD46-E8D18EEF6DE2Q40948487-7F9DD892-C28A-4540-B09E-A91922489B87Q41389079-34ABBE05-EE46-46CF-8D08-E33F56AD1C90Q41868063-7AB1EE80-CCAA-4D55-885F-543105496F18Q41881898-5D9E58AE-5BCF-49E7-90F3-2C2BB873F650Q41918244-9A47C610-D91B-40EE-8E9D-D0DDFD4F32E5Q42087888-452871E5-F82A-40CD-9B25-20C6558C4915Q42103948-F9623BF3-AF30-4DFA-971D-76B8365E5AA7Q42153895-6A3B7E27-4804-4DE8-AEE0-C3BA0C904B02Q42252081-74CE9C08-1A3F-4F06-A395-F6A07FEBCC64Q42265920-F7274DE1-4264-4244-A733-4F8BFFFCCF4EQ42279647-4B6150B6-716C-431B-B98B-7DE19D70856AQ42320423-AB6602A5-4530-40B0-B068-637C70AC540BQ42780037-3144F930-3F5D-42A8-87FA-DBEB2C5302E1Q43700519-D97A84B7-DA4F-42AE-B83F-B234001F8A60
P2860
Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quantitative models of in vitr ...... application to phage therapy.
@ast
Quantitative models of in vitr ...... application to phage therapy.
@en
type
label
Quantitative models of in vitr ...... application to phage therapy.
@ast
Quantitative models of in vitr ...... application to phage therapy.
@en
prefLabel
Quantitative models of in vitr ...... application to phage therapy.
@ast
Quantitative models of in vitr ...... application to phage therapy.
@en
P2860
P50
P1433
P1476
Quantitative models of in vitr ...... r application to phage therapy
@en
P2093
Robert J H Payne
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000253
P577
2009-01-02T00:00:00Z